Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:MSPR 3 November 2025 - 17 November 2025

MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

MSP Recovery (MSPR) surged as much as 40% in pre-market trading on November 17, 2025, reaching $0.62 after closing at $0.45 on Friday. The spike came amid heavy volume and no new company news, as traders responded to recent volatility, a late Q3 filing, and ongoing Nasdaq delisting risk. Market cap remains below $1 million, with the company facing a $1.56 billion net loss in 2024 and a $1.2 billion debt restructuring.
17 November 2025
··
MSP Recovery (MSPR) rockets pre‑market on heavy volume as traders eye earnings timing and Nasdaq listing fight — Nov. 11, 2025

MSP Recovery (MSPR) rockets pre‑market on heavy volume as traders eye earnings timing and Nasdaq listing fight — Nov. 11, 2025

MSP Recovery (LifeWallet) shares surged as much as 93% to $0.61 in Tuesday’s pre-market, with nearly 59 million shares traded, before volatile swings reversed earlier double-digit losses. Conflicting third-party earnings calendars and heavy micro-cap flows fueled the sharp moves. The company remains under pressure to avoid a Nasdaq delisting after a recent reverse stock split and ongoing debt restructuring efforts.
11 November 2025
···
MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

MSP Recovery shares closed at $0.22 on Nov. 3 after swinging from $0.19 to $0.70 in volatile trading, erasing a pre-market surge. The stock has lost over 99% from its 52-week high and faces possible Nasdaq delisting. The company recently secured interim funding and executed a 1-for-7 reverse split. MSPR, a healthcare claims recovery firm, remains deeply unprofitable despite claims of $1 billion in potential assets.
3 November 2025
·

Stock Market Today

  • Evertz Technologies Fair Value Targets Lifted by Analysts on TSX
    March 20, 2026, 2:37 PM EDT. Analysts have raised the fair value estimate for Evertz Technologies (TSX:ET) from CA$14.88 to CA$17.25, reflecting a roughly 16% increase and aligning with a cluster of price targets between CA$16 and CA$17.50. Canaccord and BMO Capital have each lifted their price targets to CA$17.50, maintaining positive ratings, while RBC Capital has raised its target incrementally to CA$16 but retains a cautious Sector Perform stance. The upward revisions follow updated assumptions, including a slight dip in revenue growth to 4.16% and an improved net profit margin to 12.98%. The stock's quarterly dividend was declared at CA$0.2050 per share, payable March 2026. Investors should note the narrowed upside range and potential risks flagged, advising careful consideration of entry points and expectations.
Go toTop